Zohreh Rahimi1. 1. Medical Biology Research Center and Department of Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Abstract
CONTEXT: Angiotensin converting enzyme (ACE) gene encodes ACE, a key component of renin angiotensin system (RAS), plays an important role in blood pressure homeostasis by generating the vasoconstrictor peptide angiotensin II. EVIDENCE ACQUISITIONS: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched. RESULTS: The presence of ACE insertion/deletion (I/D) polymorphism affects the plasma level of ACE. ACE DD genotype is associated with the highest systemic and renal ACE levels compared with the lowest ACE activity in carriers of II genotype. CONCLUSIONS: In this review focus has been performed on the study of ACE I/D polymorphism in various populations and its influence on the risk of onset and progression of diabetic nephropathy. Also, association between ACE I/D polymorphism and response to ACE inhibitor and angiotensin II receptor antagonists will be reviewed. Further, synergistic effect of this polymorphism and variants of some genes on the risk of development of diabetic nephropathy will be discussed.
CONTEXT: Angiotensin converting enzyme (ACE) gene encodes ACE, a key component of renin angiotensin system (RAS), plays an important role in blood pressure homeostasis by generating the vasoconstrictor peptide angiotensin II. EVIDENCE ACQUISITIONS: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched. RESULTS: The presence of ACE insertion/deletion (I/D) polymorphism affects the plasma level of ACE. ACE DD genotype is associated with the highest systemic and renal ACE levels compared with the lowest ACE activity in carriers of II genotype. CONCLUSIONS: In this review focus has been performed on the study of ACE I/D polymorphism in various populations and its influence on the risk of onset and progression of diabetic nephropathy. Also, association between ACE I/D polymorphism and response to ACE inhibitor and angiotensin II receptor antagonists will be reviewed. Further, synergistic effect of this polymorphism and variants of some genes on the risk of development of diabetic nephropathy will be discussed.
Authors: Ying Wang; Maggie C Y Ng; Wing Yee So; Peter C Y Tong; Ronald C W Ma; Chun Chung Chow; Clive S Cockram; Juliana C N Chan Journal: Diabetes Care Date: 2005-02 Impact factor: 19.112
Authors: S K Ha; S Yong Lee; H Su Park; J Ho Shin; S Jung Kim; D Hun Kim; K Rae Kim; H Yung Lee; D Suk Han Journal: Nephrol Dial Transplant Date: 2000-10 Impact factor: 5.992
Authors: Samy Hadjadj; Lise Tarnow; Carol Forsblom; Gbenga Kazeem; Michel Marre; Per-Henrik Groop; Hans-Henrik Parving; François Cambien; David A Tregouet; Ivo G Gut; Alexandre Théva; Dominique Gauguier; Martin Farrall; Roger Cox; Fumihiko Matsuda; Mark Lathrop; Nathalie Hager-Vionnet Journal: J Am Soc Nephrol Date: 2007-03-21 Impact factor: 10.121
Authors: Violeta J Rodriguez; Antonio Chahine; Manasi S Parrish; Maria L Alcaide; Tae Kyoung Lee; Barry Hurwitz; Manisha Sawhney; Stephen M Weiss; Deborah L Jones; Mahendra Kumar Journal: AIDS Care Date: 2020-05-13